Fibromyalgia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Individuals of both sexes; living in the Greater Florianópolis region, aged between 18 and 79 years; diagnosed with chronic pain for at least the last three months and undergoing pharmacological treatment prescribed by their attending physician will be included in this study; Patients who agree to participate in the study must sign an Informed Consent Form (ICF) and meet the criteria required above
Exclusion criteria
Exclusion criteria: Individuals with untreated immunosuppressive; oncological; infectious; renal; hepatic; gastrointestinal or psychiatric diseases; using anti-inflammatory drugs or drugs that affect the inflammatory process one week before blood collections; pregnant or lactating women; patients with herniated discs with motor deficit; post-surgery spine or rheumatic diseases, through medical diagnosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the prefrontal cortex activity, determined through cerebral blood flow at baseline and end of study | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the activity of the Autonomic Nervous System (ANS), determined through the analysis of Heart Rate Variability (HRV) at the beginning of the study and at the end of the study;To evaluate the pain, determined through the visual analogue scale (VAS) at baseline and end of study;To evaluate the body composition, determined through bioimpedance at baseline and end of study;To evaluate the blood concentration of BDNF (Brain-Derived Neurotrophic Factor), determined by the ELISA method at baseline and end of study | — |
Countries
Brazil
Contacts
Universidade do Sul de Santa Catarina